Over 60 years of life-saving research and humane animal care
After more than three decades of groundbreaking research, mentorship, and leadership at UW–Madison and the WNPRC, David Abbott, PhD has retired leaving behind a legacy in reproductive science. This interview reflects on Abbott’s contributions to Polyendocrine Metabolic Ovary Syndrome (PMOS, formerly known as Polycystic Ovary Syndrome or PCOS), his students and trainees, and a career …
WNPRC scientist David Abbott received the UW Department of OB-GYN’s Curet Award for Educational Excellence, honoring his teaching and mentorship.
By Jordana Lenon Doctors frequently administer synthetic estradiol that mimics ovarian estradiol to alleviate sexual and metabolic dysfunction in women who have had ovariectomies for cysts, cancer or other problems. But this hormone only works to varying degrees. Furthermore, it may increase the risk of harmful side-effects, including cardiovascular disease and cancer. Recently, scientists at …
The Androgren Excess & PCOS Society has awarded its 2021 Ricardo Azziz Distinguished Researcher Award to David Abbott. The award was created through an endowment to recognize distinguished leadership in the field of androgen excess and polycystic ovary syndrome (PCOS) research. The award supports the vision of the Society as an international leader in fostering the highest …
By Jacqueline N. Rubin, WNPRC editorial intern By Jacqueline N. Rubin, WNPRC editorial intern Oct. 28, 2020 A special issue of Current Opinion in Endocrine and Metabolic Research (COEMR) focusing on polycystic ovary syndrome (PCOS) has drawn praise from clinicians for its insights into the disease’s diversity, complexity and pathogenic origins. David Abbott, PhD, at …